NCT01487967

Brief Summary

This pilot intervention study will test the feasibility and acceptability and explore the outcomes of an urban, primary care-based intervention to measure families' preferences and goals for Attention-Deficit/Hyperactivity Disorder (ADHD) treatment and structure clinical care to reach these goals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2012

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 8, 2011

Completed
24 days until next milestone

Study Start

First participant enrolled

January 1, 2012

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

July 21, 2016

Status Verified

July 1, 2016

Enrollment Period

3.4 years

First QC Date

December 5, 2011

Last Update Submit

July 19, 2016

Conditions

Keywords

Attention Deficit Hyperactivity DisorderADHDPreferencesGoalsDecision Making

Outcome Measures

Primary Outcomes (1)

  • Feasibility of family recruitment and follow-up

    The feasibility of this intervention will be assessed by examining the proportion of families screened that meet enrollment criteria, the proportion meeting enrollment criteria that enroll, and the proportion enrolled that complete each study measure.

    Up to 24 months

Secondary Outcomes (7)

  • Joint Participation in Decision-Making and Partnership

    Baseline

  • Treatment Acceptability

    Baseline, after 3 months, after 6 months

  • Parent Engagement

    Up to 24 months

  • Treatment Adherence/Receipt

    Up to 24 months

  • Clinical Outcomes

    Baseline, after 3 months, after 6 months

  • +2 more secondary outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Families in the intervention arm will receive culturally appropriate educational material, complete the Preference and Goal Instrument at the study start, use the results to inform decision making about ADHD treatment, have their preferences/goals tracked in the electronic health record, and have their progress toward their goals assessed at 3 months and 6 months (approximately).

Other: Preference and Goal Instrument

Control

NO INTERVENTION

Parents will receive education on ADHD and its treatment, and otherwise receive standard care.

Interventions

Families in the intervention arm will receive culturally appropriate educational material, complete the Preference and Goal Instrument at the study start, use the results to inform decision making about ADHD treatment, have their preferences/goals tracked in the electronic health record, and have their progress toward their goals assessed at 3 months and 6 months (approximately).

Intervention

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All interested non-trainee clinicians at study sites
  • Parents/legal guardians of children age 6-12, in K-6 grade, diagnosed with ADHD.

You may not qualify if:

  • child diagnosed with autism or a psychotic disorder
  • parents non-English speaking
  • parents unable to provide consent
  • pediatric residents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Alexander G Fiks, MD, MSCE

    Children's Hospital of Philadelphia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 5, 2011

First Posted

December 8, 2011

Study Start

January 1, 2012

Primary Completion

June 1, 2015

Study Completion

June 1, 2016

Last Updated

July 21, 2016

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will not share

Locations